Emerald Health Therapeutics, Inc. Acquires Shares of Vanc Pharmaceuticals Inc.

257
0
SHARE

VICTORIA, British Columbia, Nov. 29, 2017 — Emerald Health Therapeutics, Inc. (TSX-V:EMH) (OTCQX:EMHTF) (“Emerald” or the “Company”) announces that it acquired today 1,666,6667 units (the “Units”) of Vanc Pharmaceuticals Inc. (“Vanc”) of Suite 810 – 789 West Pender Street, Vancouver, British Columbia, V6C 1H2 at a price of $0.15 per Unit pursuant to a private placement offering (the “Transaction”). Each Unit consists of one common share of Vanc (a “Share”) and one common share purchase warrant. Each whole warrant entitles the holder thereof to purchase one additional Share for a period of 60 months at an exercise price of $0.20.

Powered by WPeMatico